Jiangsu Lanfeng Bio-chemicalLtd Past Earnings Performance
Past criteria checks 0/6
Jiangsu Lanfeng Bio-chemicalLtd has been growing earnings at an average annual rate of 5.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 6% per year.
Key information
5.1%
Earnings growth rate
8.1%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 6.0% |
Return on equity | -4,777.9% |
Net Margin | -15.9% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Stock Catapults 107% Though Its Price And Business Still Lag The Industry
Nov 09Benign Growth For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Underpins Its Share Price
Sep 25Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Jun 07The Market Doesn't Like What It Sees From Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues Yet As Shares Tumble 26%
Feb 29Revenue & Expenses Breakdown
How Jiangsu Lanfeng Bio-chemicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 2,405 | -381 | 183 | 68 |
30 Jun 24 | 2,064 | -380 | 199 | 49 |
31 Mar 24 | 1,738 | -348 | 171 | 40 |
31 Dec 23 | 1,742 | -332 | 174 | 15 |
30 Sep 23 | 1,117 | -445 | 158 | 15 |
30 Jun 23 | 1,148 | -411 | 140 | 14 |
31 Mar 23 | 1,388 | -336 | 119 | 13 |
01 Jan 23 | 1,445 | -321 | 104 | 12 |
30 Sep 22 | 1,449 | -461 | 137 | 5 |
30 Jun 22 | 1,627 | -479 | 159 | 8 |
31 Mar 22 | 1,549 | -492 | 175 | 11 |
01 Jan 22 | 1,444 | -491 | 175 | 13 |
30 Sep 21 | 1,349 | -38 | 157 | 15 |
30 Jun 21 | 1,404 | 11 | 156 | 12 |
31 Mar 21 | 1,438 | 31 | 155 | 14 |
31 Dec 20 | 1,342 | 15 | 177 | 16 |
30 Sep 20 | 1,398 | -533 | 387 | 23 |
30 Jun 20 | 1,295 | -548 | 399 | 30 |
31 Mar 20 | 1,378 | -545 | 421 | 32 |
31 Dec 19 | 1,504 | -517 | 425 | 35 |
30 Sep 19 | 1,518 | -812 | 327 | 37 |
30 Jun 19 | 1,351 | -884 | 384 | 37 |
31 Mar 19 | 1,395 | -889 | 393 | 41 |
31 Dec 18 | 1,481 | -875 | 410 | 45 |
30 Sep 18 | 1,696 | -93 | 406 | 55 |
30 Jun 18 | 1,918 | 5 | 326 | 82 |
31 Mar 18 | 1,916 | 42 | 346 | 70 |
31 Dec 17 | 1,851 | 35 | 342 | 58 |
30 Sep 17 | 1,735 | 113 | 309 | 34 |
30 Jun 17 | 1,628 | 104 | 335 | 0 |
31 Mar 17 | 1,507 | 96 | 319 | 0 |
31 Dec 16 | 1,457 | 107 | 317 | 0 |
30 Sep 16 | 1,263 | 58 | 262 | 0 |
30 Jun 16 | 1,115 | 4 | 257 | 0 |
31 Mar 16 | 1,038 | -32 | 244 | 0 |
31 Dec 15 | 1,010 | -69 | 234 | 0 |
30 Sep 15 | 1,067 | -63 | 202 | 0 |
30 Jun 15 | 1,144 | -49 | 178 | 0 |
31 Mar 15 | 1,253 | -45 | 155 | 0 |
31 Dec 14 | 1,252 | -37 | 137 | 0 |
30 Sep 14 | 1,277 | -19 | 131 | 0 |
30 Jun 14 | 1,322 | -4 | 134 | 0 |
31 Mar 14 | 1,345 | 8 | 147 | 0 |
31 Dec 13 | 1,372 | 21 | 155 | 0 |
Quality Earnings: 002513 is currently unprofitable.
Growing Profit Margin: 002513 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002513 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.1% per year.
Accelerating Growth: Unable to compare 002513's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002513 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 002513 has a negative Return on Equity (-4777.92%), as it is currently unprofitable.